STEINMAN LAWRENCE
Insider CIK 1132679 · BCEL Director · ATNF Director · BCAB Director · KTTA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KTTA Pasithea Therapeutics Corp | A Award deriv | 2026-05-01 | 2026-05-05 | 152,783 | — | $0 | 152,783 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | P Buy | 2025-11-28 | 2025-12-01 | 133,333 | $0.75 | $100.0K | 199,691 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award deriv | 2025-10-24 | 2025-10-27 | 242,913 | — | $0 | 242,913 | SEC↗ |
| BCAB BioAtla, Inc. | A Award | 2025-06-18 | 2025-06-18 | 23,500 | — | $0 | 78,459 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award deriv | 2025-06-17 | 2025-06-20 | 110,000 | — | $0 | 110,000 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award deriv | 2025-06-17 | 2025-06-30 | 110,000 | — | $0 | 110,000 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award | 2025-06-17 | 2025-06-20 | 48,198 | — | $0 | 115,732 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award | 2025-06-17 | 2025-06-30 | 44,959 | — | $0 | 112,493 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award | 2025-02-20 | 2025-02-21 | 65,000 | — | $0 | 67,534 | SEC↗ |
| BCAB BioAtla, Inc. | A Award | 2024-06-13 | 2024-06-14 | 16,500 | — | $0 | 54,959 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award deriv | 2024-03-01 | 2024-04-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award deriv | 2024-03-01 | 2024-03-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BCAB BioAtla, Inc. | P Buy | 2023-12-19 | 2023-12-19 | 20,000 | $2.05 | $41.0K | 38,459 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award deriv | 2023-09-04 | 2023-09-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BCAB BioAtla, Inc. | A Award deriv | 2023-06-14 | 2023-06-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | P Buy | 2023-06-02 | 2023-06-06 | 30,000 | $0.43 | $12.9K | 1,327,174 | SEC↗ |
| ATNF 180 Life Sciences Corp. | P Buy | 2023-06-01 | 2023-06-02 | 18,000 | $1.23 | $22.1K | 48,129 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award | 2022-11-28 | 2022-11-28 | 5,000 | $0.98 | $4.9K | 1,287,174 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award | 2022-11-22 | 2022-11-22 | 5,000 | $0.99 | $5.0K | 1,282,174 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award | 2022-10-26 | 2022-10-26 | 5,000 | $1.10 | $5.5K | 1,277,174 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award | 2022-10-17 | 2022-10-17 | 9,000 | $1.13 | $10.2K | 1,272,174 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award | 2022-10-17 | 2022-10-17 | 1,000 | $1.14 | $1.1K | 1,263,174 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award | 2022-06-29 | 2022-06-30 | 5,000 | $1.00 | $5.0K | 1,272,174 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award | 2022-06-28 | 2022-06-30 | 5,000 | $1.02 | $5.1K | 1,267,174 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award | 2022-06-27 | 2022-06-27 | 5,000 | $1.00 | $5.0K | 1,262,174 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award | 2022-06-23 | 2022-06-23 | 5,000 | $1.00 | $5.0K | 1,257,174 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award | 2022-06-21 | 2022-06-22 | 652,174 | — | $0 | 1,252,174 | SEC↗ |
| BCAB BioAtla, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ATNF 180 Life Sciences Corp. | P Buy | 2021-12-09 | 2021-12-10 | 5,000 | $4.27 | $21.3K | 602,574 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award deriv | 2021-12-08 | 2021-12-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BCAB BioAtla, Inc. | S Sale | 2021-11-02 | 2021-11-03 | 450 | $30.00 | $13.5K | 18,459 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award | 2021-09-30 | 2021-10-05 | 5,216 | $6.00 | $31.3K | 597,574 | SEC↗ |
| BCAB BioAtla, Inc. | S Sale | 2021-09-15 | 2021-09-17 | 450 | $36.82 | $16.6K | 18,909 | SEC↗ |
| BCAB BioAtla, Inc. | S Sale | 2021-08-16 | 2021-08-18 | 450 | $40.60 | $18.3K | 19,359 | SEC↗ |
| KTTA Pasithea Therapeutics Corp | A Award deriv | 2021-08-02 | 2022-06-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BCAB BioAtla, Inc. | S Sale | 2021-07-15 | 2021-07-19 | 450 | $38.29 | $17.2K | 19,809 | SEC↗ |
| BCAB BioAtla, Inc. | A Award deriv | 2021-06-15 | 2021-06-16 | 12,307 | — | $0 | 12,307 | SEC↗ |
| BCAB BioAtla, Inc. | J Other | 2021-06-14 | 2021-06-16 | 5,388 | — | $0 | 20,259 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award | 2021-04-07 | 2021-04-08 | 22,585 | $6.14 | $138.7K | 592,358 | SEC↗ |
| BCEL Atreca, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-24 | 8,405 | — | $0 | 0 | SEC↗ |
| BCEL Atreca, Inc. | C Conversion | 2019-06-24 | 2019-06-24 | 8,405 | — | $0 | 258,405 | SEC↗ |